Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Carmustine 1件: Carmustine1件: D00254 --5件: 11, 13, 14, 28, 60
2 Chloride ion 1件: Chloride---29件: 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 271, 288, 296, 297, 299, 338
3 Chlorpheniramine 1件: Clorfenamina4件: D00665 ,
D00668 ,
D07398 ,
D07803 		1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 14
4 Clostridium tetani toxoid antigen (formaldehyde inactivated) 4件: Boostrix; Nimenrix; Tetanus toxoid; Tetanus toxoid adsorbed---4件: 13, 14, 46, 50
5 Corticotropin 5件: ACTH; ACTHAR; Adrenocorticotropic Hormone; Corticotrophin; Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬15件: 2, 13, 14, 46, 49, 50, 66, 75, 78, 81, 84, 145, 193, 205, 222
6 Cyclophosphamide 6件: Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamidum; Cytoxan2件: D00287 ,
D07760 		--45件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331
7 Cytarabine 1件: Cytarabine3件: D00168 ,
D03046 ,
D03637 		--7件: 11, 13, 14, 25, 49, 60, 65
8 Dalfampridine 7件: 4-Aminopyridine; 4-AP; AMPYRA; Dalfampridine; FAMPRIDINA; FAMPRIDINE; FAMPYRA1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬5件: 3, 4, 6, 13, 14
9 Dexamethasone 5件: Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex9件: D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
10 Eculizumab 2件: Eculizumab; SOLIRIS1件: D03940 1件: C5 💬10件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 11, 13, 14, 61, 62, 109, 222
11 Efgartigimod alfa 1件: EFGARTIGIMOD ALFA1件: D11876 1件: FCGRT 💬-4件: 11, 14, 35, 63
12 Etoposide 1件: Etoposide2件: D00125 ,
D04107 		2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331
13 Fibrinogen human 3件: Fibrinogen; Fibrinogen concentrate; HUMAN FIBRINOGEN---3件: 14, 65, 288
14 Fingolimod 2件: Fingolimod; Gilenya1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156
15 Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen 2件: Act-HiB; ActHIB---5件: 14, 61, 62, 66, 222
16 Human immunoglobulin G 18件: Bivigam; CUTAQUIG; CUVITRU; GAMMAGARD LIQUID; Gammaplex; GAMUNEX-C; Hizentra; Human immunoglobulin G; HUMAN NORMAL IMMUNOGLOBULIN; HYQVIA; Immune globulin; Immunoglobulin; IMMUNOGLOBULIN G; IVIg; KIOVIG; PANZYGA; Privigen; Vivaglobin---11件: 11, 13, 14, 17, 35, 43, 45, 50, 51, 63, 65
17 Hyaluronidase 2件: Hyaluronidase; Hyaluronoglucosaminidase3件: D04455 ,
D04456 ,
D06604 		--5件: 14, 28, 51, 65, 331
18 Hyaluronidase (human recombinant) 3件: Hyaluronidase; HyQvia; Recombinant human hyaluronidase---3件: 14, 28, 65
19 Lipoic acid 3件: Alpha Lipoic Acid; Alpha-lipoic acid; Lipoic acid2件: D00048 ,
D00086 		--5件: 2, 5, 13, 14, 20
20 Melphalan 3件: ALKERAN; Melphalan; Melphalan Hydrochloride1件: D00369 --15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299
21 Methylprednisolone 4件: Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE6件: D00407 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
22 Prednisolone 3件: Prednisolona; Prednisolone; Prednisolonum8件: D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
23 Prednisone 3件: Prednisona; PREDNISONE; RAYOS1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331
24 Rituximab 6件: MABTHERA; Rituxan; RITUXIMAB; Rixathon; Ruxience; Truxima1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬49件: 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
25 Rozanolixizumab 1件: ROZANOLIXIZUMAB1件: D12182 1件: FCGRT 💬-3件: 11, 14, 63
26 Sodium chloride 6件: Lactated Ringers; Natriumchlorid; REBIF; SALINE; SODIUM CHLORIDE; SPORANOX1件: D02056 --21件: 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 168, 193, 227, 228, 271, 288, 299
27 Streptococcus pneumoniae type 1 capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222
28 Streptococcus pneumoniae type 14 capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222
29 Streptococcus pneumoniae type 18c capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222
30 Streptococcus pneumoniae type 19a capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222
31 Streptococcus pneumoniae type 19f capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222
32 Streptococcus pneumoniae type 23f capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222
33 Streptococcus pneumoniae type 3 capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222
34 Streptococcus pneumoniae type 4 capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222
35 Streptococcus pneumoniae type 5 capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222
36 Streptococcus pneumoniae type 6b capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222
37 Streptococcus pneumoniae type 7f capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222
38 Streptococcus pneumoniae type 9v capsular polysaccharide antigen 2件: Pneumovax 23; Prevenar 13---6件: 13, 14, 46, 50, 96, 222